Cargando…

Development and multicenter validation of a CT-based radiomics signature for predicting severe COVID-19 pneumonia

OBJECTIVES: To develop and validate a radiomics nomogram for timely predicting severe COVID-19 pneumonia. MATERIALS AND METHODS: Three hundred and sixteen COVID-19 patients (246 non-severe and 70 severe) were retrospectively collected from two institutions and allocated to training, validation, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Liang, Wang, Li, Zeng, Feifei, Peng, Gongling, Ke, Zan, Liu, Huan, Zha, Yunfei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009273/
https://www.ncbi.nlm.nih.gov/pubmed/33786655
http://dx.doi.org/10.1007/s00330-021-07727-x
_version_ 1783672847298723840
author Li, Liang
Wang, Li
Zeng, Feifei
Peng, Gongling
Ke, Zan
Liu, Huan
Zha, Yunfei
author_facet Li, Liang
Wang, Li
Zeng, Feifei
Peng, Gongling
Ke, Zan
Liu, Huan
Zha, Yunfei
author_sort Li, Liang
collection PubMed
description OBJECTIVES: To develop and validate a radiomics nomogram for timely predicting severe COVID-19 pneumonia. MATERIALS AND METHODS: Three hundred and sixteen COVID-19 patients (246 non-severe and 70 severe) were retrospectively collected from two institutions and allocated to training, validation, and testing cohorts. Radiomics features were extracted from chest CT images. Radiomics signature was constructed based on reproducible features using the least absolute shrinkage and selection operator (LASSO) logistic regression algorithm with 5-fold cross-validation. Logistic regression modeling was employed to build different models based on quantitative CT features, radiomics signature, clinical factors, and/or the former combined features. Nomogram performance for severe COVID-19 prediction was assessed with respect to calibration, discrimination, and clinical usefulness. RESULTS: Sixteen selected features were used to build the radiomics signature. The CT-based radiomics model showed good calibration and discrimination in the training cohort (AUC, 0.9; 95% CI, 0.843–0.942), the validation cohort (AUC, 0.878; 95% CI, 0.796–0.958), and the testing cohort (AUC, 0.842; 95% CI, 0.761–0.922). The CT-based radiomics model showed better discrimination capability (all p < 0.05) compared with the clinical factors joint quantitative CT model (AUC, 0.781; 95% CI, 0.708–0.843) in the training cohort, the validation cohort (AUC, 0.814; 95% CI, 0.703–0.897), and the testing cohort (AUC, 0.696; 95% CI, 0.581–0.796). Decision curve analysis demonstrated that in terms of clinical usefulness, the radiomics model outperformed the clinical factors model and quantitative CT model alone. CONCLUSIONS: The CT-based radiomics signature shows favorable predictive efficacy for severe COVID-19, which might assist clinicians in tailoring precise therapy. KEY POINTS: • Radiomics can be applied in CT images of COVID-19 and radiomics signature was an independent predictor of severe COVID-19. • CT-based radiomics model can predict severe COVID-19 with satisfactory accuracy compared with subjective CT findings and clinical factors. • Radiomics nomogram integrated with the radiomics signature, subjective CT findings, and clinical factors can achieve better severity prediction with improved diagnostic performance.
format Online
Article
Text
id pubmed-8009273
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-80092732021-03-31 Development and multicenter validation of a CT-based radiomics signature for predicting severe COVID-19 pneumonia Li, Liang Wang, Li Zeng, Feifei Peng, Gongling Ke, Zan Liu, Huan Zha, Yunfei Eur Radiol Imaging Informatics and Artificial Intelligence OBJECTIVES: To develop and validate a radiomics nomogram for timely predicting severe COVID-19 pneumonia. MATERIALS AND METHODS: Three hundred and sixteen COVID-19 patients (246 non-severe and 70 severe) were retrospectively collected from two institutions and allocated to training, validation, and testing cohorts. Radiomics features were extracted from chest CT images. Radiomics signature was constructed based on reproducible features using the least absolute shrinkage and selection operator (LASSO) logistic regression algorithm with 5-fold cross-validation. Logistic regression modeling was employed to build different models based on quantitative CT features, radiomics signature, clinical factors, and/or the former combined features. Nomogram performance for severe COVID-19 prediction was assessed with respect to calibration, discrimination, and clinical usefulness. RESULTS: Sixteen selected features were used to build the radiomics signature. The CT-based radiomics model showed good calibration and discrimination in the training cohort (AUC, 0.9; 95% CI, 0.843–0.942), the validation cohort (AUC, 0.878; 95% CI, 0.796–0.958), and the testing cohort (AUC, 0.842; 95% CI, 0.761–0.922). The CT-based radiomics model showed better discrimination capability (all p < 0.05) compared with the clinical factors joint quantitative CT model (AUC, 0.781; 95% CI, 0.708–0.843) in the training cohort, the validation cohort (AUC, 0.814; 95% CI, 0.703–0.897), and the testing cohort (AUC, 0.696; 95% CI, 0.581–0.796). Decision curve analysis demonstrated that in terms of clinical usefulness, the radiomics model outperformed the clinical factors model and quantitative CT model alone. CONCLUSIONS: The CT-based radiomics signature shows favorable predictive efficacy for severe COVID-19, which might assist clinicians in tailoring precise therapy. KEY POINTS: • Radiomics can be applied in CT images of COVID-19 and radiomics signature was an independent predictor of severe COVID-19. • CT-based radiomics model can predict severe COVID-19 with satisfactory accuracy compared with subjective CT findings and clinical factors. • Radiomics nomogram integrated with the radiomics signature, subjective CT findings, and clinical factors can achieve better severity prediction with improved diagnostic performance. Springer Berlin Heidelberg 2021-03-30 2021 /pmc/articles/PMC8009273/ /pubmed/33786655 http://dx.doi.org/10.1007/s00330-021-07727-x Text en © European Society of Radiology 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Imaging Informatics and Artificial Intelligence
Li, Liang
Wang, Li
Zeng, Feifei
Peng, Gongling
Ke, Zan
Liu, Huan
Zha, Yunfei
Development and multicenter validation of a CT-based radiomics signature for predicting severe COVID-19 pneumonia
title Development and multicenter validation of a CT-based radiomics signature for predicting severe COVID-19 pneumonia
title_full Development and multicenter validation of a CT-based radiomics signature for predicting severe COVID-19 pneumonia
title_fullStr Development and multicenter validation of a CT-based radiomics signature for predicting severe COVID-19 pneumonia
title_full_unstemmed Development and multicenter validation of a CT-based radiomics signature for predicting severe COVID-19 pneumonia
title_short Development and multicenter validation of a CT-based radiomics signature for predicting severe COVID-19 pneumonia
title_sort development and multicenter validation of a ct-based radiomics signature for predicting severe covid-19 pneumonia
topic Imaging Informatics and Artificial Intelligence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009273/
https://www.ncbi.nlm.nih.gov/pubmed/33786655
http://dx.doi.org/10.1007/s00330-021-07727-x
work_keys_str_mv AT liliang developmentandmulticentervalidationofactbasedradiomicssignatureforpredictingseverecovid19pneumonia
AT wangli developmentandmulticentervalidationofactbasedradiomicssignatureforpredictingseverecovid19pneumonia
AT zengfeifei developmentandmulticentervalidationofactbasedradiomicssignatureforpredictingseverecovid19pneumonia
AT penggongling developmentandmulticentervalidationofactbasedradiomicssignatureforpredictingseverecovid19pneumonia
AT kezan developmentandmulticentervalidationofactbasedradiomicssignatureforpredictingseverecovid19pneumonia
AT liuhuan developmentandmulticentervalidationofactbasedradiomicssignatureforpredictingseverecovid19pneumonia
AT zhayunfei developmentandmulticentervalidationofactbasedradiomicssignatureforpredictingseverecovid19pneumonia